Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer.
about
Vitamin A and retinoid derivatives for lung cancer: a systematic review and meta analysisFER tyrosine kinase (FER) overexpression mediates resistance to quinacrine through EGF-dependent activation of NF-kappaBPEA-15 facilitates EGFR dephosphorylation via ERK sequestration at increased ER-PM contacts in TNBC cellsTyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical ImplicationsSoluble Epidermal Growth Factor Receptors (sEGFRs) in Cancer: Biological Aspects and Clinical RelevanceCurrent Management Strategies in Breast Cancer by Targeting Key Altered Molecular PlayersTransactivation of Epidermal Growth Factor Receptor by G Protein-Coupled Receptors: Recent Progress, Challenges and Future ResearchThe distinctive nature of adenocarcinoma of the lungCurrent status and perspectives of targeted therapy in well-differentiated neuroendocrine tumorsTumor heterogeneity and resistance to EGFR-targeted therapy in advanced nonsmall cell lung cancer: challenges and perspectivesCIP4 promotes lung adenocarcinoma metastasis and is associated with poor prognosis.Structural, Biochemical, and Clinical Characterization of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations in Lung CancerMechanisms of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance and Strategies to Overcome Resistance in Lung AdenocarcinomaThe epsin protein family: coordinators of endocytosis and signalingMolecular imaging of EGFR/HER2 cancer biomarkers by protein MRI contrast agentsCurcumin-the paradigm of a multi-target natural compound with applications in cancer prevention and treatmentIdentification of potent EGFR inhibitors from TCM Database@TaiwanSpecific and sensitive hydrolysis probe-based real-time PCR detection of epidermal growth factor receptor variant III in oral squamous cell carcinomaProtein tyrosine phosphatase UBASH3B is overexpressed in triple-negative breast cancer and promotes invasion and metastasis.EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.Clinicopathological features of Chinese lung cancer patients with epidermal growth factor receptor mutation.Detection of elevated plasma levels of epidermal growth factor receptor before breast cancer diagnosis among hormone therapy users.The quest to overcome resistance to EGFR-targeted therapies in cancer.Targeting the sheddase activity of ADAM17 by an anti-ADAM17 antibody D1(A12) inhibits head and neck squamous cell carcinoma cell proliferation and motility via blockage of bradykinin induced HERs transactivationEarly growth response-1 induces and enhances vascular endothelial growth factor-A expression in lung cancer cellsEffectiveness of gefitinib against non-small-cell lung cancer with the uncommon EGFR mutations G719X and L861Q.Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications.Erlotinib response in an NSCLC patient with a novel compound G719D+L861R mutation in EGFR.Mutated genes, pathways and processes in tumours.YM155 induces EGFR suppression in pancreatic cancer cells.EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancerEGFR-mutated lung cancer: a paradigm of molecular oncology.Differential regulation of transcription factors by location-specific EGF receptor signaling via a spatio-temporal interplay of ERK activation.FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway.EGFR Signaling in Colorectal Carcinoma.Amelioration of hypercholesterolemia by an EGFR tyrosine kinase inhibitor in mice with liver-specific knockout of Mig-6.Distinctive mechanism for sustained TGF-β signaling and growth inhibition: MEK1 activation-dependent stabilization of type II TGF-β receptors.Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine model.Occludin is regulated by epidermal growth factor receptor activation in brain endothelial cells and brains of mice with acute liver failure.Spectrum of EGFR gene copy number changes and KRAS gene mutation status in Korean triple negative breast cancer patients.
P2860
Q21089955-DAA3249B-09CB-413A-9B36-39DB37CD9578Q24300387-AA8E87A0-E4CB-4BE3-B046-B3B77F49248FQ24323230-A7C364D0-F6F6-42C0-AF39-726B26012B03Q26741318-15BBAD4F-0479-4827-B701-DDB2CB8754E8Q26750970-D5B2CAF9-EBBA-4A0E-B774-84333928D02BQ26765877-87F4F0F6-B2B7-4182-8CD2-79D3FD13A5F0Q26771727-4CA9481B-1C4C-4494-827A-A54712D444D6Q26781159-75419CCE-5E8C-4577-976C-AE44E90D43B7Q26823873-27CE37B6-E4DE-4A22-A8EB-19A04BB7CE50Q27014117-6AC98520-D197-4FD2-8DDE-B9C94BECDC38Q27310110-755E2FDD-FD12-49EC-A436-81E62576770DQ27680966-6A0EB973-6CB3-4EB8-A2D7-B15FEAE25E58Q28069900-FBB5D5AF-CA99-428F-A390-4861E8939263Q28274114-EF9000A4-D468-4749-8A3D-681412B56292Q28304646-CA319C7E-6750-4C69-9A7B-5E6824A5534AQ28393316-70793B81-388C-4312-86EB-4F297C2DDFC5Q28477481-D581ECF8-60CE-4321-AF45-DA76AE5B38D2Q28732052-5CD02C6C-1A45-4ADB-85EC-AA1F689454B4Q30009828-A1C908A5-3468-4ECE-8BD1-EA9526CF60E9Q33276007-EAE36437-BD2B-4F95-B81B-A96C36161537Q33571227-EBC6864E-0074-4649-AF2A-348E450F39C3Q33722935-500B2D06-7018-47F0-A026-8EA2E1845B77Q33725976-960FE529-C842-41E6-96A0-94ED87E3CFB4Q33845082-EFF968AC-77D4-408C-930F-CE2489E2F979Q33947163-7E05363D-2B91-47BD-B812-66306926DF65Q34041701-2C42630E-F4D7-4008-9675-13A5DAF7E72CQ34091593-286C72C7-9E74-4DCC-82DE-F021107A7E5FQ34134464-46A03EC0-F2BD-4C71-86BB-A567496E4172Q34166906-31394DC1-87C7-4F1E-A918-3685CB6DDBA9Q34313903-AD40405D-969B-4911-95BB-1876471D2F0AQ34365738-F79ECE76-C5C4-44E8-8A96-A896410483C6Q34406334-D959FB1B-86E8-41B3-8EEA-CA4D4E69212DQ34415844-8AA629C5-3CD6-435B-A3D5-1A1A6A5B7683Q34419405-927091BF-2F65-4420-90E5-B19939FE4DBCQ34627605-568AD0D4-2018-4D86-B352-FE4558D0029DQ34655000-C6E79421-1179-411D-B528-8E00A54C1F68Q34793617-E7D172DA-2058-4994-A058-9426FD55F96EQ34810321-1680A02E-0B8E-4E04-9605-177E8501F9BDQ34813587-8BC3C499-5438-4C42-BF96-CD7E0D22D7ABQ35036895-1CD493CF-B797-43FF-9383-B2AA174A06D3
P2860
Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer.
@en
Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer.
@nl
type
label
Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer.
@en
Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer.
@nl
prefLabel
Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer.
@en
Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer.
@nl
P2860
P1433
P1476
Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer.
@en
P2860
P304
P356
10.1111/J.1742-4658.2009.07448.X
P407
P577
2009-11-18T00:00:00Z